Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).
Clinical trial NCT04230148 · COMPLETED
Trial details
- NCT number
- NCT04230148
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2026-03-27
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.